Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Gasherbrum Bio patents GLP-1 receptor agonists

Nov. 18, 2021

Medshine Discovery discloses new MAPK inhibitors

Nov. 18, 2021

Accutar Biotechnology describes new compounds for cancer

Nov. 17, 2021

Shenzhen Jingtai Technology discloses new Ret inhibitors

Nov. 17, 2021

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Nov. 17, 2021

Chinese researchers divulge GTPase KRAS mutant inhibitors

Nov. 17, 2021

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Plexxikon identifies new CD73 inhibitors

Nov. 16, 2021

Taiho Pharmaceutical presents new GTPase KRAS mutant inhibitors

Nov. 16, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026